A tetravalent RGD ligand for integrin-mediated cell adhesion

Monovalent RGD (arginine‐glycine‐aspartic acid) peptides or polymers furnished with RGD in random distributions are employed as cell‐scaffolds and gene delivery vehicles. However, integrin binding to RGD is dependent on the spatial distribution (clustering) of the ligand and intrinsic integrin affin...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of pharmacy and pharmacology 2006-07, Vol.58 (7), p.959-966
Hauptverfasser: Watson, N., Duncan, G., Annan, W. S., van der Walle, C. F.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 966
container_issue 7
container_start_page 959
container_title Journal of pharmacy and pharmacology
container_volume 58
creator Watson, N.
Duncan, G.
Annan, W. S.
van der Walle, C. F.
description Monovalent RGD (arginine‐glycine‐aspartic acid) peptides or polymers furnished with RGD in random distributions are employed as cell‐scaffolds and gene delivery vehicles. However, integrin binding to RGD is dependent on the spatial distribution (clustering) of the ligand and intrinsic integrin affinity via conformational changes (avidity). Here we have designed and expressed a polypeptide consisting of a tetrameric coiled coil and spacer facilitating polyvalent (clustered) display of integrin ligands; the RGD motif was used as proof of principle. Size‐exclusion chromatography and circular dichroism showed that the polypeptide self assembled as a tetramer in solution with a defined secondary structure. Cell adhesion to surfaces coated with the polypeptide was up to 3‐fold greater than that for (monovalent) RGDS peptide at equivalent concentrations. Moreover, the polypeptide in solution at concentrations ≥1μM inhibited cell adhesion to fibronectin‐coated surfaces, while RGDS peptide in solution at concentrations up to 500μM did not. These cell data demonstrate that the polypeptide bound integrin receptors in a polyvalent manner. The polypeptide will therefore be of use in the engineering of tissue‐culture scaffolds with increased cell adhesion activity, or to targeted gene delivery vehicles, and could incorporate protein ligands in place of the RGD motif.
doi_str_mv 10.1211/jpp.58.7.0011
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_68586716</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>68586716</sourcerecordid><originalsourceid>FETCH-LOGICAL-c4110-111d1671eabc48aa599f9023f0ae6199807e6ab23f1c8d6768320d42da501a633</originalsourceid><addsrcrecordid>eNp9kMtOwzAQRS0EgvJYskVZsUuYsetHJDY8U1CBCoG6tNzEAUOaFDsF-vekagU7ViONzhzduYQcIiRIEU_eZrOEq0QmAIgbpEehT2OJXG2SHgClMeOS7ZDdEN4AQAohtskOCgU85aJHTs-i1rbefJrK1m30mF1GlXsxdRGVjY9c3doX7-p4agtnWltEua2qyBSvNrim3idbpamCPVjPPfJ8ffV0MYiHD9nNxdkwzvuIECNigUKiNZO8r4zhaVqmQFkJxgpMUwXSCjPpFpirQkihGIWiTwvDAY1gbI8cr7wz33zMbWj11IVlElPbZh60UFx1ftGB8QrMfROCt6WeeTc1fqER9LIu3dWludJSL-vq-KO1eD7pXvyj1_10AF0BX66yi_9t-nY0GKUM_lK40Nrv3yPj37WQTHI9vs-0HLD0HMaZvmM_DBaC6g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>68586716</pqid></control><display><type>article</type><title>A tetravalent RGD ligand for integrin-mediated cell adhesion</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><source>Oxford University Press Journals All Titles (1996-Current)</source><creator>Watson, N. ; Duncan, G. ; Annan, W. S. ; van der Walle, C. F.</creator><creatorcontrib>Watson, N. ; Duncan, G. ; Annan, W. S. ; van der Walle, C. F.</creatorcontrib><description>Monovalent RGD (arginine‐glycine‐aspartic acid) peptides or polymers furnished with RGD in random distributions are employed as cell‐scaffolds and gene delivery vehicles. However, integrin binding to RGD is dependent on the spatial distribution (clustering) of the ligand and intrinsic integrin affinity via conformational changes (avidity). Here we have designed and expressed a polypeptide consisting of a tetrameric coiled coil and spacer facilitating polyvalent (clustered) display of integrin ligands; the RGD motif was used as proof of principle. Size‐exclusion chromatography and circular dichroism showed that the polypeptide self assembled as a tetramer in solution with a defined secondary structure. Cell adhesion to surfaces coated with the polypeptide was up to 3‐fold greater than that for (monovalent) RGDS peptide at equivalent concentrations. Moreover, the polypeptide in solution at concentrations ≥1μM inhibited cell adhesion to fibronectin‐coated surfaces, while RGDS peptide in solution at concentrations up to 500μM did not. These cell data demonstrate that the polypeptide bound integrin receptors in a polyvalent manner. The polypeptide will therefore be of use in the engineering of tissue‐culture scaffolds with increased cell adhesion activity, or to targeted gene delivery vehicles, and could incorporate protein ligands in place of the RGD motif.</description><identifier>ISSN: 0022-3573</identifier><identifier>EISSN: 2042-7158</identifier><identifier>DOI: 10.1211/jpp.58.7.0011</identifier><identifier>PMID: 16805956</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Amino Acid Sequence ; Animals ; Cell Adhesion - drug effects ; Circular Dichroism ; Cloning, Molecular ; Electrophoresis, Polyacrylamide Gel ; Escherichia coli - genetics ; Fibroblasts - cytology ; Fibroblasts - drug effects ; HeLa Cells ; Humans ; Integrins ; Ligands ; Mice ; Molecular Sequence Data ; Oligopeptides - chemistry ; Oligopeptides - genetics ; Oligopeptides - pharmacology</subject><ispartof>Journal of pharmacy and pharmacology, 2006-07, Vol.58 (7), p.959-966</ispartof><rights>2006 Royal Pharmaceutical Society of Great Britain</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c4110-111d1671eabc48aa599f9023f0ae6199807e6ab23f1c8d6768320d42da501a633</citedby><cites>FETCH-LOGICAL-c4110-111d1671eabc48aa599f9023f0ae6199807e6ab23f1c8d6768320d42da501a633</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1211%2Fjpp.58.7.0011$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1211%2Fjpp.58.7.0011$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,777,781,1412,27905,27906,45555,45556</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/16805956$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Watson, N.</creatorcontrib><creatorcontrib>Duncan, G.</creatorcontrib><creatorcontrib>Annan, W. S.</creatorcontrib><creatorcontrib>van der Walle, C. F.</creatorcontrib><title>A tetravalent RGD ligand for integrin-mediated cell adhesion</title><title>Journal of pharmacy and pharmacology</title><addtitle>J Pharm Pharmacol</addtitle><description>Monovalent RGD (arginine‐glycine‐aspartic acid) peptides or polymers furnished with RGD in random distributions are employed as cell‐scaffolds and gene delivery vehicles. However, integrin binding to RGD is dependent on the spatial distribution (clustering) of the ligand and intrinsic integrin affinity via conformational changes (avidity). Here we have designed and expressed a polypeptide consisting of a tetrameric coiled coil and spacer facilitating polyvalent (clustered) display of integrin ligands; the RGD motif was used as proof of principle. Size‐exclusion chromatography and circular dichroism showed that the polypeptide self assembled as a tetramer in solution with a defined secondary structure. Cell adhesion to surfaces coated with the polypeptide was up to 3‐fold greater than that for (monovalent) RGDS peptide at equivalent concentrations. Moreover, the polypeptide in solution at concentrations ≥1μM inhibited cell adhesion to fibronectin‐coated surfaces, while RGDS peptide in solution at concentrations up to 500μM did not. These cell data demonstrate that the polypeptide bound integrin receptors in a polyvalent manner. The polypeptide will therefore be of use in the engineering of tissue‐culture scaffolds with increased cell adhesion activity, or to targeted gene delivery vehicles, and could incorporate protein ligands in place of the RGD motif.</description><subject>Amino Acid Sequence</subject><subject>Animals</subject><subject>Cell Adhesion - drug effects</subject><subject>Circular Dichroism</subject><subject>Cloning, Molecular</subject><subject>Electrophoresis, Polyacrylamide Gel</subject><subject>Escherichia coli - genetics</subject><subject>Fibroblasts - cytology</subject><subject>Fibroblasts - drug effects</subject><subject>HeLa Cells</subject><subject>Humans</subject><subject>Integrins</subject><subject>Ligands</subject><subject>Mice</subject><subject>Molecular Sequence Data</subject><subject>Oligopeptides - chemistry</subject><subject>Oligopeptides - genetics</subject><subject>Oligopeptides - pharmacology</subject><issn>0022-3573</issn><issn>2042-7158</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2006</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kMtOwzAQRS0EgvJYskVZsUuYsetHJDY8U1CBCoG6tNzEAUOaFDsF-vekagU7ViONzhzduYQcIiRIEU_eZrOEq0QmAIgbpEehT2OJXG2SHgClMeOS7ZDdEN4AQAohtskOCgU85aJHTs-i1rbefJrK1m30mF1GlXsxdRGVjY9c3doX7-p4agtnWltEua2qyBSvNrim3idbpamCPVjPPfJ8ffV0MYiHD9nNxdkwzvuIECNigUKiNZO8r4zhaVqmQFkJxgpMUwXSCjPpFpirQkihGIWiTwvDAY1gbI8cr7wz33zMbWj11IVlElPbZh60UFx1ftGB8QrMfROCt6WeeTc1fqER9LIu3dWludJSL-vq-KO1eD7pXvyj1_10AF0BX66yi_9t-nY0GKUM_lK40Nrv3yPj37WQTHI9vs-0HLD0HMaZvmM_DBaC6g</recordid><startdate>200607</startdate><enddate>200607</enddate><creator>Watson, N.</creator><creator>Duncan, G.</creator><creator>Annan, W. S.</creator><creator>van der Walle, C. F.</creator><general>Blackwell Publishing Ltd</general><scope>BSCLL</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200607</creationdate><title>A tetravalent RGD ligand for integrin-mediated cell adhesion</title><author>Watson, N. ; Duncan, G. ; Annan, W. S. ; van der Walle, C. F.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c4110-111d1671eabc48aa599f9023f0ae6199807e6ab23f1c8d6768320d42da501a633</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2006</creationdate><topic>Amino Acid Sequence</topic><topic>Animals</topic><topic>Cell Adhesion - drug effects</topic><topic>Circular Dichroism</topic><topic>Cloning, Molecular</topic><topic>Electrophoresis, Polyacrylamide Gel</topic><topic>Escherichia coli - genetics</topic><topic>Fibroblasts - cytology</topic><topic>Fibroblasts - drug effects</topic><topic>HeLa Cells</topic><topic>Humans</topic><topic>Integrins</topic><topic>Ligands</topic><topic>Mice</topic><topic>Molecular Sequence Data</topic><topic>Oligopeptides - chemistry</topic><topic>Oligopeptides - genetics</topic><topic>Oligopeptides - pharmacology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Watson, N.</creatorcontrib><creatorcontrib>Duncan, G.</creatorcontrib><creatorcontrib>Annan, W. S.</creatorcontrib><creatorcontrib>van der Walle, C. F.</creatorcontrib><collection>Istex</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of pharmacy and pharmacology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Watson, N.</au><au>Duncan, G.</au><au>Annan, W. S.</au><au>van der Walle, C. F.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>A tetravalent RGD ligand for integrin-mediated cell adhesion</atitle><jtitle>Journal of pharmacy and pharmacology</jtitle><addtitle>J Pharm Pharmacol</addtitle><date>2006-07</date><risdate>2006</risdate><volume>58</volume><issue>7</issue><spage>959</spage><epage>966</epage><pages>959-966</pages><issn>0022-3573</issn><eissn>2042-7158</eissn><abstract>Monovalent RGD (arginine‐glycine‐aspartic acid) peptides or polymers furnished with RGD in random distributions are employed as cell‐scaffolds and gene delivery vehicles. However, integrin binding to RGD is dependent on the spatial distribution (clustering) of the ligand and intrinsic integrin affinity via conformational changes (avidity). Here we have designed and expressed a polypeptide consisting of a tetrameric coiled coil and spacer facilitating polyvalent (clustered) display of integrin ligands; the RGD motif was used as proof of principle. Size‐exclusion chromatography and circular dichroism showed that the polypeptide self assembled as a tetramer in solution with a defined secondary structure. Cell adhesion to surfaces coated with the polypeptide was up to 3‐fold greater than that for (monovalent) RGDS peptide at equivalent concentrations. Moreover, the polypeptide in solution at concentrations ≥1μM inhibited cell adhesion to fibronectin‐coated surfaces, while RGDS peptide in solution at concentrations up to 500μM did not. These cell data demonstrate that the polypeptide bound integrin receptors in a polyvalent manner. The polypeptide will therefore be of use in the engineering of tissue‐culture scaffolds with increased cell adhesion activity, or to targeted gene delivery vehicles, and could incorporate protein ligands in place of the RGD motif.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>16805956</pmid><doi>10.1211/jpp.58.7.0011</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0022-3573
ispartof Journal of pharmacy and pharmacology, 2006-07, Vol.58 (7), p.959-966
issn 0022-3573
2042-7158
language eng
recordid cdi_proquest_miscellaneous_68586716
source MEDLINE; Wiley Online Library Journals Frontfile Complete; Oxford University Press Journals All Titles (1996-Current)
subjects Amino Acid Sequence
Animals
Cell Adhesion - drug effects
Circular Dichroism
Cloning, Molecular
Electrophoresis, Polyacrylamide Gel
Escherichia coli - genetics
Fibroblasts - cytology
Fibroblasts - drug effects
HeLa Cells
Humans
Integrins
Ligands
Mice
Molecular Sequence Data
Oligopeptides - chemistry
Oligopeptides - genetics
Oligopeptides - pharmacology
title A tetravalent RGD ligand for integrin-mediated cell adhesion
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-20T15%3A28%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=A%20tetravalent%20RGD%20ligand%20for%20integrin-mediated%20cell%20adhesion&rft.jtitle=Journal%20of%20pharmacy%20and%20pharmacology&rft.au=Watson,%20N.&rft.date=2006-07&rft.volume=58&rft.issue=7&rft.spage=959&rft.epage=966&rft.pages=959-966&rft.issn=0022-3573&rft.eissn=2042-7158&rft_id=info:doi/10.1211/jpp.58.7.0011&rft_dat=%3Cproquest_cross%3E68586716%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=68586716&rft_id=info:pmid/16805956&rfr_iscdi=true